H2 Equity Partners (“H2”) agrees to acquire specialty chemicals company William Blythe from Synthomer plc in partnership with the management team.

Founded in 1845, William Blythe is a global leader in the manufacture of speciality inorganic chemicals that form critical inputs to products across a range of industries including healthcare, electronics, automotive, construction products, energy and consumer goods. William Blythe works with leading global synthesisers and manufacturers, leveraging market-leading in-house R&D capabilities and deep experience in formulating chemicals to fit the required application to support customers in the development of their own products. Key product segments for William Blythe include flame retardants, thermal stabilisers, absorbents and catalysts. 

Following H2’s investment, the management team of David Crossley, Kevin Hudson and Michael Butler will continue to lead the business and work closely with H2 to deliver William Blythe’s ambitious growth strategy and ensure it continues to provide high-quality products to its customers and further develop its innovative and evolving product portfolio. 

The transaction is conditional on certain customary closing conditions and is expected to complete at the end of May. 

For further information on William Blythe, please refer to https://williamblythe.com